|[February 27, 2013]
John Muir Health Pilots Early Warning System For Heart Attack Patients
WALNUT CREEK, Calif. --(Business Wire)--
Reducing the time it takes heart attack patients to receive treatment
significantly increases their chances of survival and minimizes
long-term damage to the heart and brain.
John Muir Health's Clinical Research Center recently began a clinical
trial to test the effectiveness and safety of an implantable cardiac
monitor and alert system that acts as an early warning system. The
device is designed to reduce the time it takes patients to get to the
emergency room during an impending heart attack.
John Muir Health is one of the first medical facilities in the country
to participate in the ALERTS US trial for the AngelMed Guardian
implantable cardiac monitor and alert system (Guardian System). Patients
potentially eligible for the study include those who have been diagnosed
with unstable angina or who, within the past six months, have had a
heart attack, undergone coronary artery bypass surgery or are scheduled
for that surgery within the next six months.
"The Guardian System is designed to track significant changes in the
heart's electrical signal," said Ayman Hosny, M.D., a cardiologist at
John Muir Health and principal investigator for the ALERTS trial. "When
someone has a heart attack, it is typically the result of a blood clot
closing one of the three major coronary arteries. When this happens,
there is a shift in the heart's electrical signal. Notification of that
shift can be the difference between a debilitating, even fatal, heart
attack and life-saving treatment."
According to David Fischell, Ph.D., CEO, AngelMed, the objective of the
ALERTS trial is to test the Guardian System's ability to detect this
electrical shift and provide an early warning system to patients.
The ngelMed Guardian System is comprised of an internal implantable
device, a standard pacemaker lead and an external telemetry device. The
device monitors the heart's electrical signal 24 hours-a-day, 7
days-a-week looking for changes that may indicate the heart is not
getting enough oxygen, which may lead to a heart attack. When the
implanted monitor detects a potential heart attack, it vibrates,
alerting the person to take action. In addition to the vibration, it
communicates with a pager-sized device that both beeps and flashes,
letting the person know that they need to either call their doctor or
Once the person is at the hospital, their doctor can retrieve
information collected by the implanted device to a computer. This
information can help the doctor determine the best course of action in
providing treatment and care.
According to the American Heart Association, one out of every six deaths
in the United States is attributable to coronary heart disease. Each
year, an estimated 785,000 Americans will have a new coronary attack,
and 470,000 will have a recurrent attack. Approximately every 34
seconds, an American will have a heart attack. It is also estimated that
an additional 195,000 people annually will have a silent heart attack
with few, if any, symptoms.
"If the Guardian system proves to be effective in early detection and
warning of potentially life-threatening heart conditions, we may be able
to shift the model of care for high-risk patients to focus on early
intervention at the onset of a heart attack," said Dr. Hosny.
For more information on the AngelMed Guardian System or participation in
the ALERTS study, contact the John Muir Health Clinical Research Center
About John Muir Health Clinical Research Center
The John Muir Health Clinical Research Center has participated in over
200 clinical research studies through National Cancer
Institute-sponsored cooperative groups, as well as pharmaceutical and
biotechnological industry-sponsored studies. Our research experience
includes Phase II, III, and IV drug and device clinical research studies
for prevention, early detection and treatment of various conditions.
Many John Muir Health Clinical Research Center staff are certified
through the Association of Clinical Research Professionals (ACRP) or the
Society of Clinical Research Associates (SoCRA).
About John Muir Health
John Muir Health is a nationally recognized, not-for-profit health care
organization located east of San Francisco, serving patients in Contra
Costa, eastern Alameda and southern Solano Counties. It includes a
network of 925 primary care and specialty physicians, more than 6,000
employees, medical centers in Concord and Walnut Creek, including the
county's only trauma center, and a Behavioral Health Center. The health
system also offers a full-range of medical services, including primary
care, outpatient, lab and imaging services, and is widely recognized as
a leader in many specialties - neurosciences, orthopedic, cancer,
cardiovascular, emergency and high-risk obstetrics care. For more
information, visit www.johnmuirhealth.com.
[ Back To TMCnet.com's Homepage ]